MARKED ACCUMULATION OF VALPROIC ACID IN EMBRYONIC NEUROEPITHELIUM OF THE MOUSE DURING EARLY ORGANOGENESIS

被引:34
作者
DENCKER, L [1 ]
NAU, H [1 ]
DARGY, R [1 ]
机构
[1] FREE UNIV BERLIN,INST TOXICOL & EMBRYOPHARMACOL,W-1000 BERLIN 33,GERMANY
关键词
D O I
10.1002/tera.1420410606
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Valproic acid, an antiepileptic drug, causes neural tube defects in mice and man. 14C‐labeled valproic acid (sodium‐salt) was administered to pregnant mice on days 8 and 9 of gestation (period of high sensitivity in regard to formation of neural tube defects in this species). Two dose levels of valproic acid (1 and 400 mg/kg) were used; in each case the total radioactivity administered was the same: 400 μCi/kg or 14.7 MBq/kg. Autoradiography combined with computerized densitometry revealed that in low‐dose animals most of the radioactivity was confined to maternal liver and kidney, while at high doses more activity was observed in soft tissues and fluids, including amniotic fluid. In the embryo, the neuroepithelium showed the highest concentration, irrespective of dose and survival interval (30 min, 3 h, and 6 h). Upon administration of the high dose, up to five times more radioactivity (approximately 2,000 times more valproic acid) was recovered in embryonic tissues than after the low dose. It is concluded that high doses of VPA saturate the capacities of metabolism, excretion, and protein binding in the maternal organism, resulting in a higher proportion of the dose reaching the embryo, allowing more of the drug to be accumulated by the target organ, the neuroepithelium. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:699 / 706
页数:8
相关论文
共 25 条
[1]   TERATOGENIC EFFECTS OF VALPROIC ACID AND DIPHENYLHYDANTOIN ON MOUSE EMBRYOS IN CULTURE [J].
BRUCKNER, A ;
LEE, YJ ;
OSHEA, KS ;
HENNEBERRY, RC .
TERATOLOGY, 1983, 27 (01) :29-42
[2]  
CLARKE DO, 1987, ARCH TOXICOL S, V2, P143
[3]   SHORT-CHAIN CARBOXYLIC-ACIDS, A NEW CLASS OF TERATOGENS - STUDIES OF POTENTIAL BIOCHEMICAL-MECHANISMS [J].
COAKLEY, ME ;
RAWLINGS, SJ ;
BROWN, NA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1986, 70 :105-111
[4]  
DARGY R, 1990, IN PRESS J PHARM MET
[5]   SATURABLE ACCUMULATION OF RETINOIC ACID IN NEURAL AND NEURAL CREST DERIVED CELLS IN EARLY EMBRYONIC-DEVELOPMENT [J].
DENCKER, L ;
DARGY, R ;
DANIELSSON, BRG ;
GHANTOUS, H ;
SPERBER, GO .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1987, 10 (03) :212-223
[6]  
DENCKER L, 1987, PHARMACOKINETICS TER, V1, P56
[7]  
GHANTOUS H, 1990, TOXICOL PHARM, V66, P87
[8]   FETAL GROWTH, MAJOR MALFORMATIONS, AND MINOR ANOMALIES IN INFANTS BORN TO WOMEN RECEIVING VALPROIC ACID [J].
JAGERROMAN, E ;
DEICHL, A ;
JAKOB, S ;
HARTMANN, AM ;
KOCH, S ;
RATING, D ;
STELDINGER, R ;
NAU, H ;
HELGE, H .
JOURNAL OF PEDIATRICS, 1986, 108 (06) :997-1004
[9]  
KAO J, 1981, Teratogenesis Carcinogenesis and Mutagenesis, V1, P367, DOI 10.1002/tcm.1770010405
[10]   PHARMACOKINETIC ASPECTS OF DRUG EFFECTS INVITRO - EFFECTS OF SERUM-PROTEIN BINDING ON CONCENTRATION AND TERATOGENICITY OF VALPROIC ACID AND 2-EN-VALPROIC ACID IN WHOLE EMBRYOS IN CULTURE [J].
LEWANDOWSKI, C ;
KLUG, S ;
NAU, H ;
NEUBERT, D .
ARCHIVES OF TOXICOLOGY, 1986, 58 (04) :239-242